Bioresorbable Vascular Scaffold in Patients With Myocardial Infarction

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT02151929

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
San Giuseppe Moscati Hospital (from the registry)
Registry
  • NCT NCT02151929
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02151929. Randomized; no masking; primary purpose treatment. Start 2013-05 (registry gives no type); primary completion 2013-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Bioresorbable Vascular Scaffold in Patients With Myocardial Infarction
Condition
ST Elevation Acute Myocardial Infarction
Intervention (Device)
Bioresorbable vascular scaffold
Intervention (Device)
Everolimus eluting stent
Lead sponsor
San Giuseppe Moscati Hospital (class: other)

Record details

Record id
cardio:ct-nct02151929
Content hash
fec420e4304a0a7c66b91a9ff2af167e97b596b8fe5a852eb85f9a87ba246266